Social anxiety and premorbid personality disorders in paranoid schizophrenic patients treated with clozapine

CNS Spectrums

Volumn 5, Issue 9, 2000, Pages 29-43

  Pallanti, S ^a   Quercioli, L ^a   Pazzagli, A ^a  

^a Psichiatria P   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUOXETINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DRUG EFFECT; EXPERIENCE; FEMALE; HUMAN; MALE; PARANOID SCHIZOPHRENIA; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHODYNAMICS; RATING SCALE; RELAPSE; SOCIAL INTERACTION; SOCIAL PHOBIA; SUICIDE;

EID: 0033804852     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900021635     Document Type: Article

References (87)

1. Der sensitive beziehungwahn
2. The American Journal of Psychiatry. The onset of schizophrenia: 1927
3. Notes on some schizoid mechanisms
4. The psychopathology of the psychoses: A proposed revision
5. The Brief Psychiatric Rating Scale
6. Separation anxiety: A factor in the object relations of schizophrenic patients
7. The pre-therapeutic classification of comorbidity in chronic disease
8. Schizotaxia, schizotypy, schizophrenia
9. Obsessive-compulsive spectrum disorders: An overview
10. Psychopathology, temperament, and past course in primary major depressions: Review of evidence for a bipolar spectrum
11. The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder
12. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders
13. Panic attacks in patients with chronic schizophrenia: A complication of long-term neuroleptic treatment
14. The many faces of akathisia
15. Development of transient obsessive-compulsive symptoms during treatment with clozapine
16. Emergence of obsessive compulsive symptoms during treatment with clozapine
17. Development of obsessive compulsive symptoms during clozapine treatment
18. Can Clozapine trigger OCD?
19. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline
20. Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients
21. The importance of serotonin-dopamine interactions in the action of clozapine
22. Die welt des zwangskranken
23. The concept of schizophrenia
24. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder
25. Depression, demoralisation and control over psychotic illness: A comparison of depressed and non-depressed patients with a chronic psychosis
26. Anxiety and suicide
27. Effects of clozapine on awareness of illness and cognition in schizophrenia
28. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample: The national comorbidity survey
29. 2 receptor occupancy in relation to clozapine serum concentration: A PET study of schizophrenic patients
30. The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation
31. Relapse in young schizophrenic patients: A prospective study of stressful life events, P300 measures, and coping
32. The Brief Psychiatric Rating Scale
33. Social phobia
34. FBF
35. Axis II diagnoses and treatment refractoriness in schizophrenia
36. Comorbidity in schizophrenia: A prognostic study of personality disorders in recovered and non-recovered schizophrenia patients
37. Behavioral precursors of schizophrenia spectrum: A prospective study
38. The search for a schizotype: Crossing the border again
39. Relationship of schizotypal personality disorder to schizophrenia: Genetics
40. Childhood behavioral precursors of adult symptom dimensions in schizophrenia
41. Personality and psychopathology in schizophrenia: The association between personality traits and symptoms
42. Schizophrenia: Manifestations, incidence and course in different cultures: A World Health Organization ten-country study
43. Prodromal symptoms in schizophrenia
44. Premorbid personality disorders in schizophrenia
45. Social phobia: Biological aspects and pharmacotherapy
46. Dopamine reuptake site densities in patients with social phobia
47. Magnetic resonance imaging in patients with social phobia
48. Magnetic resonance spectroscopy in social phobia
49. Anxiety disorders in familial parkinsonism
50. Anxiety disorders in patients with Parkinson's disease
51. School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder
52. A systematic method for clinical description and classification of personality variants
53. 4 dopamine receptor gene and measures of novelty seeking
54. Fluoxetine efficacy in social phobia
55. Neurobiology of social phobia
56. A syndrome of increased affect in response to risperidone among patients with schizophrenia
57. Separation anxiety in children and adolescents treated with risperidone
58. Olanzapine-induced obsessive-compulsive disorder
59. New-onset panic attacks in a patient treated with olanzapine
60. Panic disorder in schizophrenia
61. Adjunctive alprazolam for chizophrenia with panic anxiety: Clinical observation and pathogenetic implications
62. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features
63. Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: An add-on open study
64. Panic attacks with psychotic features
65. Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome
66. Social anxiety in schizophrenia
67. Fluoxetine for the treatment of social phobia
68. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors
69. Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolities in patients with schizophrenia
70. Lack of effect of fluoxetine on plasma clozapine concentrations
71. High social phobia scale scores in schizophrenia do not correlate with psychosis symptom severity scores
72. True schizotypal personality disorder: A study of co-twins and relatives of schizophrenic probands
73. Schizotypal symptoms and signs in the Roscommon Family Study: Their factor structure and familial relationship with psychotic and affective disorders
74. The continuity of personality in schizophrenia